This is an enhanced safety surveillance study that will occur within the military Service Member population. Primary Objective: * To evaluate the rates of suspected, probable, and confirmed myocarditis and/or pericarditis in temporal association with ACAM2000® vaccination. Secondary Objectives: * To evaluate the rates of cardiovascular adverse events in temporal association with ACAM2000® vaccination. * To evaluate the rates of neurological adverse events in temporal association with ACAM2000® vaccination.
The Armed Forces Health Surveillance Activity (AFHSA) will perform comprehensive health surveillance through the operation of the Defense Medical Surveillance System (DMSS). Demographic and medical information gathered within monthly reports from the DMSS will be collected from approximately 100,000 to 200,000 military Service Members who received the ACAM2000® smallpox vaccine.
Study Type
OBSERVATIONAL
Enrollment
897,227
Previous vaccination, no vaccine is administered in this study.
Unnamed facility
Twentynine Palms, California, United States
Unnamed facility
Fort Campbell North, Kentucky, United States
Unnamed facility
Fort Bliss, Texas, United States
Unnamed facility
Fort Hood, Texas, United States
To provide information concerning the safety following vaccination with ACAM2000® vaccinia vaccine
Time frame: Entire study duration
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.